| Drug |
Reagent used |
Linear range
(μgmL-1) |
LOD
(μgmL-1) |
Molar absorptivity
(L mol-1 cm-1) |
Applications |
Ref. |
| Azithromycin |
Quinalizarin |
4-20 |
0.35 |
-- |
Tablets |
12 |
| |
Eosin Y |
1-10 |
-- |
-- |
Human urine, plasma |
13 |
| |
Rose Bengal |
4-20 |
0.31 |
3.78× 104 |
Tablets, capsules, syrup |
14 |
| |
Chloranilic acid |
5-225 |
-- |
2.4×103 |
Tablets |
15 |
| |
7,7,8,8-tetracyanoquinodimethane |
0-30 |
-- |
2.7×104
5.0×104 |
Tablets |
15 |
| |
Bromophenol blue |
0-50 |
0.10 |
1.369×104 |
Tablets, syrup, Human Urine |
Present work |
| Sparfloxacin |
Bromocresol purple |
5-25 |
-- |
2.988×104 |
Tablets |
16 |
| |
Bromocresol green |
5-25 |
-- |
3.152×104 |
Tablets |
16 |
| |
Ammonium vanadate |
0.8-28 |
-- |
-- |
Tablets, Human Urine |
17 |
| |
Mo(V)-thiocyanate |
10-150 |
9.00 |
62×103 |
Tablets |
19 |
| |
p- dimethyl amino-benzaldehyde |
2-80 |
0.22 |
4.9×103 |
Tablets, Human urine, Blood serum |
20 |
| |
Bromophenol blue |
10-80 |
0.21 |
3.774×103 |
Human Urine |
Present Work |
| Cephalexin monohydrate |
Molybdenum blue |
0-45 |
-- |
-- |
Capsules |
21 |
| |
Sodium 1,2-napthoquinone-4-sulphonate |
1.5-34 |
0.49 |
1.79×103 |
Capsules |
22 |
| |
p-benzoquinone |
10-160 |
-- |
1.37×103 |
Capsules |
23 |
| |
Iodine |
6-40 |
1.37 |
9.64×103 |
Capsules |
24 |
| |
2,3-Dichloro-5,6-dicyano-1,4-benzoquinone |
40-180 |
2.76 |
2.22×103 |
Capsules |
24 |
| |
7,7,8,8-tetracyanoquinodimethane |
4-12 |
0.23 |
31.90×103 |
Capsules |
24 |
|